• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SF-36量表以及量表的简单总和,对于精神分裂症患者来说是可靠的生活质量总结指标。

SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia.

作者信息

Leese Morven, Schene Aart, Koeter Maarten, Meijer Karin, Bindman Jonathan, Mazzi Mariangela, Puschner Bernd, Burti Lorenzo, Becker Thomas, Moreno Mauricio, Celani Daniela, White Ian R, Thonicroft Graham

机构信息

Health Services and Population Research Department, Institute of Psychiatry, King's College London, De Crespigny Park, London SE5 8AF, UK.

出版信息

J Clin Epidemiol. 2008 Jun;61(6):588-96. doi: 10.1016/j.jclinepi.2007.08.004. Epub 2008 Feb 14.

DOI:10.1016/j.jclinepi.2007.08.004
PMID:18471663
Abstract

OBJECTIVE

To examine the feasibility and reliability of the Medical Outcomes Study 36 Item Short Form Health Survey (SF-36) for patients with schizophrenia, focusing on the eight scales and various aggregate summary measures.

STUDY DESIGN AND SETTING

Secondary analysis of data from the European multicenter QUATRO medication adherence trial and the Regional Psychosis Project from The Netherlands. Methods included exploratory and confirmatory factor analyses and estimation of aggregate score reliability using Cronbach's alpha and Tarkkonen's generalized reliability index. The aggregate scores that were compared included two sets based on factor analyses, the standard "physical and mental health component summary scores" (PCS and MCS) and scores based on the original conceptual model of the SF-36 (simple sum of first four scales for physical health, last four for mental health).

RESULTS

The eight SF-36 scales were feasible to administer and reliable. Factor analyses of the QUATRO baseline scale data suggested two or three factors, the latter solution including a general "role limitation" factor. Aggregate scores based on the conceptual model had the highest generalized reliability of those compared.

CONCLUSION

SF-36 scales are suitable for patients with schizophrenia. Aggregate scores based on the conceptual model may be preferable to the MCS and PCS for such patients. Further investigation of factor structure is advisable.

摘要

目的

探讨医学结局研究简明健康调查问卷(SF - 36)用于精神分裂症患者的可行性和可靠性,重点关注八个分量表及各种综合汇总指标。

研究设计与背景

对来自欧洲多中心QUATRO药物依从性试验和荷兰地区精神病项目的数据进行二次分析。方法包括探索性和验证性因子分析,以及使用克朗巴赫α系数和塔尔科宁广义可靠性指数估计汇总得分的可靠性。所比较的汇总得分包括基于因子分析的两组得分、标准的“生理和心理健康综合得分”(PCS和MCS)以及基于SF - 36原始概念模型的得分(身体健康前四个量表的简单总和,心理健康后四个量表的简单总和)。

结果

SF - 36的八个分量表易于实施且可靠。QUATRO基线量表数据的因子分析表明存在两个或三个因子,后一种解法包括一个一般的“角色限制”因子。在所比较的汇总得分中,基于概念模型的得分具有最高的广义可靠性。

结论

SF - 36量表适用于精神分裂症患者。对于此类患者,基于概念模型的汇总得分可能比MCS和PCS更可取。建议进一步研究因子结构。

相似文献

1
SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia.SF-36量表以及量表的简单总和,对于精神分裂症患者来说是可靠的生活质量总结指标。
J Clin Epidemiol. 2008 Jun;61(6):588-96. doi: 10.1016/j.jclinepi.2007.08.004. Epub 2008 Feb 14.
2
The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions.儿童癌症成年幸存者中SF-36问卷的使用:数据质量、评分可靠性及量表假设评估
Health Qual Life Outcomes. 2006 Oct 5;4:77. doi: 10.1186/1477-7525-4-77.
3
The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population.SF-36简明量表在中国人群中有效、可靠且具有等效性。
J Clin Epidemiol. 2005 Aug;58(8):815-22. doi: 10.1016/j.jclinepi.2004.12.008.
4
The 12-item medical outcomes study short form health survey version 2.0 (SF-12v2): a population-based validation study from Tehran, Iran.12 项医疗结局研究简明健康调查问卷 2.0 版(SF-12v2):来自伊朗德黑兰的基于人群的验证研究。
Health Qual Life Outcomes. 2011 Mar 7;9:12. doi: 10.1186/1477-7525-9-12.
5
The SF-36 summary scales: problems and solutions.SF-36 总结量表:问题与解决方案。
Soz Praventivmed. 2000;45(6):239-46. doi: 10.1007/BF01591686.
6
Measurement properties and normative data for the Norwegian SF-36: results from a general population survey.挪威SF-36量表的测量属性及规范数据:一项普通人群调查的结果
Health Qual Life Outcomes. 2017 Mar 14;15(1):51. doi: 10.1186/s12955-017-0625-9.
7
Validation of the English version of the Kidney Disease Quality of Life questionnaire (KDQOL-36) in haemodialysis patients in Singapore.验证新加坡血液透析患者使用肾脏病生存质量量表(KDQOL-36)英文版的情况。
Patient. 2013;6(2):135-41. doi: 10.1007/s40271-013-0015-2.
8
Testing scaling assumptions, reliability and validity of medical outcomes study short-form 36 health survey in psoriatic arthritis.评估中医疗效评价研究 36 项健康调查简表在银屑病关节炎中的定标假设、信度和效度。
Rheumatology (Oxford). 2010 Aug;49(8):1495-501. doi: 10.1093/rheumatology/keq112. Epub 2010 Apr 25.
9
Measuring health-related quality of life: psychometric evaluation of the Tunisian version of the SF-12 health survey.测量健康相关生活质量:SF-12健康调查突尼斯版本的心理测量评估
Qual Life Res. 2014 Sep;23(7):2047-54. doi: 10.1007/s11136-014-0641-8. Epub 2014 Feb 11.
10
Psychometric evaluation of the Short Form 36 Health Survey (SF-36) and the World Health Organization Quality of Life Scale Brief Version (WHOQOL-BREF) for patients with schizophrenia.精神分裂症患者简明 36 健康调查量表(SF-36)和世界卫生组织生活质量量表简表(WHOQOL-BREF)的心理测量评估。
Psychol Assess. 2014 Sep;26(3):980-9. doi: 10.1037/a0036764. Epub 2014 May 5.

引用本文的文献

1
Individualized transcranial temporal interference stimulation (tTIS) for cognitive impairments and negative symptoms in patients with schizophrenia: a study protocol for a randomized controlled trial.针对精神分裂症患者认知障碍和阴性症状的个体化经颅颞叶干扰刺激(tTIS):一项随机对照试验的研究方案
BMC Psychiatry. 2025 Jul 18;25(1):714. doi: 10.1186/s12888-025-07158-8.
2
Correlation of Health-Related Quality of Life with Negative Symptoms Assessed with the Self-Evaluation of Negative Symptoms Scale (SNS) and Cognitive Deficits in Schizophrenia: A Cross-Sectional Study in Routine Psychiatric Care.精神分裂症患者健康相关生活质量与采用阴性症状自评量表(SNS)评估的阴性症状及认知缺陷的相关性:一项常规精神科护理中的横断面研究
J Clin Med. 2023 Jan 23;12(3):901. doi: 10.3390/jcm12030901.
3
Differential Physical and Mental Benefits of Physiotherapy Program Among Patients With Schizophrenia and Healthy Controls Suggesting Different Physical Characteristics and Needs.精神分裂症患者与健康对照者在物理治疗项目中的身心益处差异表明了不同的身体特征和需求。
Front Psychiatry. 2021 Feb 9;12:536767. doi: 10.3389/fpsyt.2021.536767. eCollection 2021.
4
The impact of metabolic syndrome on mental health-related quality of life and depressive symptoms.代谢综合征对心理健康相关生活质量和抑郁症状的影响。
Qual Life Res. 2020 Aug;29(8):2063-2072. doi: 10.1007/s11136-020-02479-5. Epub 2020 Mar 25.
5
Comparison of schizophrenia outpatients in residential care facilities with those living with someone: Study of mental and physical health, cognitive functioning, and biomarkers of aging.住院疗养的精神分裂症门诊患者与与他人同住的患者比较:心理健康和身体健康、认知功能以及衰老生物标志物研究。
Psychiatry Res. 2019 May;275:162-168. doi: 10.1016/j.psychres.2019.02.067. Epub 2019 Feb 27.
6
Flourishing With Psychosis: A Prospective Examination on the Interactions Between Clinical, Functional, and Personal Recovery Processes on Well-being Among Individuals with Schizophrenia Spectrum Disorders.精神病康复良好:一项对精神分裂谱系障碍个体的临床、功能和个人康复过程之间的相互作用与幸福感的前瞻性研究。
Schizophr Bull. 2018 Jun 6;44(4):778-786. doi: 10.1093/schbul/sbx120.
7
Psychometric evaluation of the Oswestry Disability Index in patients with chronic low back pain: factor and Mokken analyses.慢性下腰痛患者Oswestry功能障碍指数的心理测量学评估:因素分析和莫肯分析
Health Qual Life Outcomes. 2017 Oct 3;15(1):192. doi: 10.1186/s12955-017-0768-8.
8
Examining unidimensionality and improving reliability for the eight subscales of the SF-36 in opioid-dependent patients using Rasch analysis.使用拉施分析检验阿片类药物依赖患者中SF-36八个子量表的单维度性并提高其信度。
Qual Life Res. 2015 Feb;24(2):279-85. doi: 10.1007/s11136-014-0771-z. Epub 2014 Aug 7.
9
Exercise capacity and quality of life in patients with schizophrenia.精神分裂症患者的运动能力和生活质量。
Psychiatr Q. 2013 Dec;84(4):417-27. doi: 10.1007/s11126-013-9256-4.
10
Health-related quality of life in patients with dual diagnosis: clinical correlates.双重诊断患者的健康相关生活质量:临床相关性。
Health Qual Life Outcomes. 2012 Sep 5;10:106. doi: 10.1186/1477-7525-10-106.